cbdMD FY26 Q3 operating loss widens to $1.13 million; net sales rise 20% to $5.6 million
Reuters2026/08/13 20:18- cbdMD posted fiscal Q3 net sales of $5.6 million, up 20% year over year, driven by a 61% wholesale jump.
- Operating loss widened to $1.13 million; net loss attributable to common shareholders was $1.2 million, or $0.11 per share.
- Gross margin fell 6.8 percentage points to 54.7% on mix shift to wholesale, added warehousing/repacking, higher inventory reserves tied to regulatory changes.
- Oasis distributor depletions rose 25% in the quarter; Bluebird Botanicals added more than $0.5 million in its first full-quarter contribution.
- Management cited July cost cuts targeting $100,000-$150,000 in monthly savings, alongside one-time M&A diligence and legal costs.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The 10-year U.S. Treasury yield climbs to 4.8%, erasing the dividend advantage of utility stocks; the sector’s rebound depends on interest rate stabilization rather than technical signals.
As U.S. Treasury yields continue to climb, the American utilities sector is experiencing a significant pullback—a rise in yields not only erodes the relative appeal of the sector’s dividends but also raises financing costs for the most capital-intensive industries within this market.
Euro holds gains above 1.1600 despite robust US jobs data, traders eye ECB rate decision
Port of Tauranga wins fast-track approval for Stella Passage development
Crypto prices
More
